{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:29Z","timestamp":1792782749883,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-022-06611-3","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T09:04:22Z","timestamp":1653123862000},"page":"533-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Metastatic extent-specific prognosis of women with stage IVB cervical cancer: multiple versus single distant organ involvement"],"prefix":"10.1007","volume":"307","author":[{"given":"Sarah","family":"Joh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Violette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun U.","family":"Khetan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda D.","family":"Jooya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigita S.","family":"Cahoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"issue":"6","key":"6611_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"6611_CR2","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L et al (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8(2):e191\u2013e203","journal-title":"Lancet Glob Health"},{"issue":"10071","key":"6611_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","volume":"389","author":"O Ginsburg","year":"2017","unstructured":"Ginsburg O, Bray F, Coleman MP et al (2017) The global burden of women\u2019s cancers: a grand challenge in global health. Lancet 389(10071):847\u2013860","journal-title":"Lancet"},{"key":"6611_CR4","unstructured":"Cancer Stat Facts: Cervical Cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program. <https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html>. Accessed 12\/november\/2021"},{"issue":"Suppl 1","key":"6611_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0020-7292(06)60026-X","volume":"95","author":"JL Benedet","year":"2006","unstructured":"Benedet JL, Pecorelli S (2006) Why Cancer Staging? Int J Gynaecol Obstet 95(Suppl 1):S3","journal-title":"Int J Gynaecol Obstet"},{"key":"6611_CR6","unstructured":"Cervical cancer. NCCN clinical practice guidelines in oncology, National Comprehensive Cancer Network. https:\/\/www.nccn.org\/. Accessed 12\/september\/2021"},{"issue":"Suppl 2","key":"6611_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018) Cancer of the cervix uteri. Int J Gynaecol Obstet 143(Suppl 2):22\u201336","journal-title":"Int J Gynaecol Obstet"},{"issue":"64","key":"6611_CR8","doi-asserted-by":"publisher","first-page":"32321","DOI":"10.18632\/oncotarget.25962","volume":"9","author":"S Nishio","year":"2018","unstructured":"Nishio S, Matsuo K, Yonemoto K et al (2018) Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer. Oncotarget 9(64):32321\u201332330","journal-title":"Oncotarget"},{"issue":"7","key":"6611_CR9","first-page":"3471","volume":"36","author":"S Oishi","year":"2016","unstructured":"Oishi S, Kudaka W, Toita T et al (2016) Prognostic factors and treatment outcome for patients with stage ivb cervical cancer. Anticancer Res 36(7):3471\u20133475","journal-title":"Anticancer Res"},{"issue":"7","key":"6611_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/IGC.0000000000000771","volume":"26","author":"T Usami","year":"2016","unstructured":"Usami T, Takahashi A, Matoda M et al (2016) Review of treatment and prognosis of stage IVB cervical carcinoma. Int J Gynecol Cancer 26(7):1239\u20131245","journal-title":"Int J Gynecol Cancer"},{"key":"6611_CR11","unstructured":"National Cancer Institute\u2019s The Surveillance, Epidemiology, and End Results (SEER) Program. http:\/\/seer.cancer.gov\/. Accessed 12\/August\/2021"},{"issue":"11","key":"6611_CR12","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#","volume":"76","author":"C Zippin","year":"1995","unstructured":"Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76(11):2343\u20132350","journal-title":"Cancer"},{"key":"6611_CR13","unstructured":"National Cancer Registrars Association http:\/\/www.ncra-usa.org\/. Accessed 12\/August\/2021"},{"issue":"12","key":"6611_CR14","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1200\/JCO.2003.94.023","volume":"21","author":"LC Harlan","year":"2003","unstructured":"Harlan LC, Hankey BF (2003) The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol 21(12):2232\u20132233","journal-title":"J Clin Oncol"},{"key":"6611_CR15","unstructured":"International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3). World Health Organization. https:\/\/www.who.int\/classifications\/icd\/adaptations\/oncology\/en\/. Accessed 12\/August\/2021"},{"issue":"1","key":"6611_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ygyno.2009.09.040","volume":"116","author":"LT Gien","year":"2010","unstructured":"Gien LT, Beauchemin MC, Thomas G (2010) Adenocarcinoma: a unique cervical cancer. Gynecol Oncol 116(1):140\u2013146","journal-title":"Gynecol Oncol"},{"issue":"7645","key":"6611_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature21386","volume":"543","author":"Cancer Genome Atlas Research N","year":"2017","unstructured":"Cancer Genome Atlas Research N, Albert Einstein College of M, Analytical Biological S et al (2017) Integrated genomic and molecular characterization of cervical cancer. Nature 543(7645):378\u2013384","journal-title":"Nature"},{"issue":"2","key":"6611_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ygyno.2012.01.012","volume":"125","author":"V Galic","year":"2012","unstructured":"Galic V, Herzog TJ, Lewin SN et al (2012) Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 125(2):287\u2013291","journal-title":"Gynecol Oncol"},{"issue":"6","key":"6611_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","volume":"156","author":"AA Ghaferi","year":"2021","unstructured":"Ghaferi AA, Schwartz TA, Pawlik TM (2021) STROBE reporting guidelines for observational studies. JAMA Surg 156(6):577\u2013578","journal-title":"JAMA Surg"},{"issue":"Suppl 1","key":"6611_CR20","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/S0020-7292(06)60030-1","volume":"95","author":"MA Quinn","year":"2006","unstructured":"Quinn MA, Benedet JL, Odicino F et al (2006) Carcinoma of the cervix uteri FIGO 26th Annual Report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):S43-103","journal-title":"Int J Gynaecol Obstet"},{"key":"6611_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1200\/EDBK_175474","volume":"37","author":"CB Smith","year":"2017","unstructured":"Smith CB, Phillips T, Smith TJ (2017) Using the new ASCO clinical practice guideline for palliative care concurrent with oncology care using the TEAM approach. Am Soc Clin Oncol Educ Book 37:714\u2013723","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06611-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T11:06:41Z","timestamp":1680692801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06611-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["6611"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06611-3","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,21]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All were unrelated to the work: consultant, Quantgene (L.D.R.); none for others.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"University of Southern California (HS-16\u201300481).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}